ClinicalTrials.gg
Sign In

Vitreous Hemorrhage clinical trials

The registry lists 44 studies for Vitreous Hemorrhage across more than 10 countries. 4 are recruiting or about to start. 22 of them are mainly about Vitreous Hemorrhage (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28.

Get an email when these change. Save the Vitreous Hemorrhage studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
27
Status unknown
11
Recruiting
2
Not yet recruiting
2
Withdrawn
2

Phase

Phase 3
9
Phase 2
9
Phase 4
8
Phase 1
2

Where

United States
7
Brazil
6
Mexico
3
Hong Kong
3
Korea, Republic of
3
Taiwan
3

Who runs them

University of Sao Paulo (4) · The University of Hong Kong (3) · National Taiwan University Hospital (3) · Alcon Research (2) · Jaeb Center for Health Research (2) · National Eye Institute (NEI) (2) · Seoul National University Bundang Hospital (2) · Bausch & Lomb Incorporated (2)

What is being tested here

Drugs under test in Vitreous Hemorrhage studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Bevacizumab029
Aflibercept013
Ranibizumab013
Hyaluronidase (ovine)022
Dexamethasone001
Propofol001
Remifentanil001
Sevoflurane001
Pegaptanib011

Drug classes tested here Angiogenesis inhibitors 15

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 2 Vitreous Hemorrhage studies recruiting now, 2 (100%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 2
AgeWomenMen
100 (0%)0 (0%)
182 (100%)2 (100%)
302 (100%)2 (100%)
402 (100%)2 (100%)
502 (100%)2 (100%)
652 (100%)2 (100%)
752 (100%)2 (100%)
852 (100%)2 (100%)

Across all 44 studies, recruiting or not: 7% stop at 75 or younger and 2% at 65; 14% take children; 0% are for women only and 0% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 44 of 44. search them.